 |
|
Impact of Childhood Vaccination on Racial Disparities in Invasive Streptococcus pneumoniae Infections
Brendan Flannery, PhD;
Stephanie Schrag, DPhil;
Nancy M. Bennett, MD;
Ruth Lynfield, MD;
Lee H. Harrison, MD;
Arthur Reingold, MD;
Paul R. Cieslak, MD;
James Hadler, MD, MPH;
Monica M. Farley, MD;
Richard R. Facklam, PhD;
Elizabeth R. Zell, MStat;
Cynthia G. Whitney, MD, MPH; for the Active Bacterial Core Surveillance/Emerging Infections Program Network
JAMA. 2004;291:2197-2203.
Context Historically, incidence of pneumococcal disease in the United States has been higher among blacks than among whites. Following recommendation of a new 7-valent pneumococcal conjugate vaccine for children in October 2000, the incidence of invasive pneumococcal disease has declined dramatically, but the impact of vaccination on racial disparities in incidence of pneumococcal disease is unknown.
Objective To assess the effect of conjugate vaccine introduction on rates of pneumococcal disease among whites and blacks in the United States.
Design, Setting, and Patients Analysis of data from the Active Bacterial Core Surveillance (ABCs)/Emerging Infections Program Network, an active, population-based surveillance system in 7 states. Patients were 15 923 persons with invasive pneumococcal disease occurring between January 1, 1998, and December 31, 2002.
Main Outcome Measures Age- and race-specific pneumococcal disease incidence rates (cases per 100 000 persons), rate ratios, and rate differences.
Results Between 1998 and 2002, annual incidence rates for invasive pneumococcal disease decreased from 19.0 to 12.1 cases per 100 000 among whites and from 54.9 to 26.5 among blacks. Due to these declines, 14 730 fewer cases occurred among whites and 8780 fewer cases occurred among blacks in the United States in 2002, compared with 2 prevaccine years, 1998 and 1999. Before vaccine introduction, incidence among blacks was 2.9 times higher than among whites (95% confidence interval [CI], 2.7-3.0); in 2002, the black-white rate ratio had been reduced to 2.2 (95% CI, 2.0-2.4). Incidence among black children younger than 2 years went from being 3.3 times higher (95% CI, 3.0-3.7) than among white children in the prevaccine period to 1.6 times higher (95% CI, 1.1-2.2) in 2002. By 2002, 74% of white children and 68% of black children aged 19 to 35 months in the 7 states had received at least 1 dose of pneumococcal conjugate vaccine; 43% of white and 39% of black children received 3 or more doses.
Conclusion Although blacks remain at higher risk of invasive pneumococcal disease, introduction of childhood pneumococcal vaccination has reduced the racial disparity in incidence of pneumococcal disease.
Author Affiliations Division of Bacterial and Mycotic Diseases, National Center for Infectious Diseases, US Centers for Disease Control and Prevention, Atlanta, Ga (Drs Flannery, Schrag, Facklam, and Whitney and Ms Zell); Monroe County Department of Health and University of Rochester, Rochester, NY (Dr Bennett); Minnesota Department of Health, Minneapolis (Dr Lynfield); Johns Hopkins University Bloomberg School of Public Health, Baltimore, Md (Dr Harrison); School of Public Health, University of California, Berkeley (Dr Reingold); Oregon Department of Human Service, Office of Disease Prevention and Epidemiology, Portland (Dr Cieslak); Connecticut Department of Public Health, Hartford (Dr Hadler); Emory University School of Medicine and the Veterans Affairs Medical Center, Atlanta, Ga (Dr Farley).
RELATED ARTICLE
Race-Based Immunization Recommendations and the Potential to Reduce Health Disparities
Matthew M. Davis
JAMA. 2004;291(18):2253-2255.
EXTRACT
| FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Seasonal Invasive Pneumococcal Disease in Children: Role of Preceding Respiratory Viral Infection
Ampofo et al.
Pediatrics 2008;122:229-237.
ABSTRACT
| FULL TEXT
Effectiveness of the 7-Valent Pneumococcal Conjugate Vaccine in Children With Sickle Cell Disease in the First Decade of Life
Adamkiewicz et al.
Pediatrics 2008;121:562-569.
ABSTRACT
| FULL TEXT
Health Care Utilization for Pneumonia in Young Children After Routine Pneumococcal Conjugate Vaccine Use in the United States
Zhou et al.
Arch Pediatr Adolesc Med 2007;161:1162-1168.
ABSTRACT
| FULL TEXT
Invasive Pneumococcal Disease Caused by Nonvaccine Serotypes Among Alaska Native Children With High Levels of 7-Valent Pneumococcal Conjugate Vaccine Coverage
Singleton et al.
JAMA 2007;297:1784-1792.
ABSTRACT
| FULL TEXT
Invasive Pneumococcal Disease: The Target Is Moving
Peters and Poehling
JAMA 2007;297:1825-1826.
FULL TEXT
National Health Care Visit Patterns of Adolescents: Implications for Delivery of New Adolescent Vaccines
Rand et al.
Arch Pediatr Adolesc Med 2007;161:252-259.
ABSTRACT
| FULL TEXT
The Impact of Conjugate Pneumococcal Vaccination on Routine Childhood Vaccination and Primary Care Use in 2 Counties
Szilagyi et al.
Pediatrics 2006;118:1394-1402.
ABSTRACT
| FULL TEXT
Vaccine Preventable Diseases and Vaccination Policy for Indigenous Populations
Menzies and McIntyre
Epidemiol Rev 2006;28:71-80.
ABSTRACT
| FULL TEXT
Impact of State Vaccine Financing Policy on Uptake of Heptavalent Pneumococcal Conjugate Vaccine
Stokley et al.
Am. J. Public Health 2006;96:1308-1313.
ABSTRACT
| FULL TEXT
Will Coverage for Child and Adolescent Immunizations Be Mandated for Insurance Plans in 2006? Lessons Learned From the Newborns' and Mothers' Health Protection Act of 1996
Mmeje and Davis
Pediatrics 2006;118:388-392.
FULL TEXT
Invasive Pneumococcal Disease Among Infants Before and After Introduction of Pneumococcal Conjugate Vaccine
Poehling et al.
JAMA 2006;295:1668-1674.
ABSTRACT
| FULL TEXT
Sequential Multiplex PCR Approach for Determining Capsular Serotypes of Streptococcus pneumoniae Isolates
Pai et al.
J. Clin. Microbiol. 2006;44:124-131.
ABSTRACT
| FULL TEXT
Clonal Association between Streptococcus pneumoniae Serotype 23A, Circulating within the United States, and an Internationally Dispersed Clone of Serotype 23F
Pai et al.
J. Clin. Microbiol. 2005;43:5440-5444.
ABSTRACT
| FULL TEXT
Fluorescent Multivalent Opsonophagocytic Assay for Measurement of Functional Antibodies to Streptococcus pneumoniae
Bieging et al.
CVI 2005;12:1238-1242.
ABSTRACT
| FULL TEXT
Use of Pyrosequencing To Differentiate Streptococcus pneumoniae Serotypes 6A and 6B
Pai et al.
J. Clin. Microbiol. 2005;43:4820-4822.
ABSTRACT
| FULL TEXT
Conjugate vaccines
Finn and Heath
Arch. Dis. Child. 2005;90:667-669.
FULL TEXT
Immunizations In The United States: Success, Structure, And Stress
Orenstein et al.
Health Aff (Millwood) 2005;24:599-610.
ABSTRACT
| FULL TEXT
Methicillin-Resistant Staphylococcus aureus Disease in Three Communities
Fridkin et al.
NEJM 2005;352:1436-1444.
ABSTRACT
| FULL TEXT
Health Care Organizations' Use Of Race/Ethnicity Data To Address Quality Disparities
Nerenz
Health Aff (Millwood) 2005;24:409-416.
ABSTRACT
| FULL TEXT
The Transformation Of Child Health In The United States
Wise
Health Aff (Millwood) 2004;23:9-25.
ABSTRACT
| FULL TEXT
Vaccine Reduces Racial Disparity in Pneumococcal Disease Incidence
JWatch Infect. Diseases 2004;2004:4-4.
FULL TEXT
Race-Based Immunization Recommendations and the Potential to Reduce Health Disparities
Davis
JAMA 2004;291:2253-2255.
FULL TEXT
|
